Keywords: fifth, indication, abbott, humira, health, care, major

Fifth indication for Abbott's Humira

Article | 28 January 2008

Print This

US health care major Abbott Laboratories has received Food and Drug Administration approval to market its Humira (adalimumab) as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in